Definitive Contract 75N91019C00041
Award Date
9/16/19
Potential Completion Date
9/15/22
Potential Value
$2M
Federal Agency
National Cancer Institute
Awardee
Mimetas US Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
MONTGOMRY VLG, MD 20877, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to Mimetas US Inc., a self-certified small disadvantaged business. The $224,998 Firm Fixed Price contract is for the "Development and Evaluation of the HepaPlate IPS: A High Throughput Organ on a Chip IPS Hepatotoxicity Screening Platform." The contract aims to develop and evaluate a high-throughput organ-on-a-chip...
This is a Phase II Small Business Innovation Research (SBIR) contract awarded by the National Cancer Institute (NCI), a civilian agency of the U.S. Department of Health and Human Services (HHS), to Nortis Inc., a for-profit manufacturer of biotechnology products and services. The contract, valued at $1,988,728.00, is for the development of a "vascularized tumor-microenvironment assay" to support the screening of anti-cancer drugs. This contract is designated as a Total Small Business...
This is a $2,000,000.00 Small Business Innovation Research (SBIR) Phase II contract awarded by the National Cancer Institute (NCI) to Micromics Technologies LLC, a for-profit limited liability company located in Spanish Fork, Utah. The contract is for the development of an "Integrated Platform and Consumables for Robust, Sensitive and High-Throughput Single-Cell Proteomics", which was the topic of a previous SBIR Phase I award. The contract is a definitive, firm-fixed-price contract...
This is a $197,673 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a part of the Department of Health and Human Services (HHS), to Molecular Express, Inc., a minority-owned and self-certified small disadvantaged business. The contract is for the development of a commercial point-of-care device capable of electronically sensing tumor cells and molecular cancer biomarkers in a patient's circulating peripheral blood. This research project...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) to Lynntech Inc., a small business. The contract is for the development of non-polydimethylsiloxane (PDMS) biocompatible alternatives for organs-on-chips, a topic under NCATS SBIR 2019 solicitation. The contract has a firm fixed-price of $225,000.00 and a completion date of January 31, 2020. Lynntech Inc. is a small business that...
This is a firm fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the Department of Health and Human Services (HHS), to Mimetas Operations US, Co., a foreign-owned, self-certified small disadvantaged business. The $150,480.00 contract is for the acquisition of Organoplate Grafts, which are microfluidic 3D cell culture plates used in scientific research projects related to SARS-CoV-2 and COVID-19. This contract was...
This Small Business Innovation Research (SBIR) Phase I contract, valued at $399,674, was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Inso Biosciences Inc., a small biotechnology startup. The contract supports the research and development of advanced sample processing platforms for downstream single-cell multi-omic analysis. This work aligns with the NIH and Centers for Disease Control and Prevention (CDC) mission to develop medical...
This is a $148,828 Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of Health and Human Services (HHS) to Meso Scale Diagnostics LLC, a small business provider of assay development services, laboratory testing equipment, and immunoassays. The contract, titled "TOPIC 238 AUTOMATED MULTI-ARRAY PLATFORM FOR CANCER BIOMARKERS," is for the development of an automated platform to detect cancer biomarkers. As a Phase I SBIR contract, this award is...
<p>This SBIR Phase I contract was awarded by the National Cancer Institute (NCI), a civilian federal agency, to Transgenex Nanobiotech Inc., a minority-owned small business, for the development of a "fibrous scaffold-induced spheroids mimicking TME" solution. The contract, valued at $299,992.00, is a definitive, firm fixed-price contract with a completion date of July 21, 2014. The contract was set aside for the participation of small businesses.</p>
This $400,000 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Amplifidx Inc., a woman-owned small business. The contract supports the development of cancer prevention and diagnosis technologies for low-resource settings over a two-year period. This award aligns with NCI's mission to support innovative medical device research and development by small businesses. As a SBIR...